Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up

The Brief Psychiatric Rating Scale.

Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090 · see citing works

Move Over ANOVA: Progress in Analyzing Repeated-Measures Data andIts Reflection in Papers Published in the <i>Archives of General Psychiatry</i>

Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529 · see citing works

Does Fast Dissociation From the Dopamine D ₂ Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140 · see citing works

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Chouinard, G., & Margolese, H. C. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.013 · Cited by 418 · see citing works

Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

Silvestri, S., Seeman, M. V., Negrete, J.-C., Houle, S., Shammi, C. M., Remington, G. J., Kapur, S., Zipursky, R. B., Wilson, A. A., Christensen, B. K., et al. (2000) · Psychopharmacology · doi:10.1007/s002130000532 · Cited by 311 · see citing works

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.1.16 · Cited by 301 · see citing works

Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review

Garfield, S., Clifford, S., Eliasson, L., Barber, N., & Willson, A. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-149 · Cited by 289 · see citing works

“Breakthrough” dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time

Samaha, A.-N., Seeman, P., Stewart, J., Rajabi, H., & Kapur, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5416-06.2007 · Cited by 262 · see citing works

Rapid Release of Antipsychotic Drugs From Dopamine D₂ Receptors: An Explanation for Low Receptor Occupancy and Early Clinical Relapse Upon Withdrawal of Clozapine or Quetiapine

Seeman, P., & Tallerico, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.876 · Cited by 237 · see citing works

Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapse

Moncrieff, J. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00787.x · Cited by 231 · see citing works

Neuroleptic-induced supersensitivity psychosis

(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1409 · Cited by 224 · see citing works

Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia

Eerdekens, M., Hove, I. V., Remmerie, B. M. M., & Mannaert, E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.11.001 · Cited by 161 · see citing works

Long-Term Treatment of Tardive Dyskinesia with Haloperidol and Tetrabenazine

Kazamatsuri, H., Chien, C., & Cole, J. O. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.4.479 · Cited by 125 · see citing works

Severe cases of neuroleptic-induced supersensitivity psychosis

Chouinard, G. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90050-2 · Cited by 123 · see citing works

Aripiprazole, a novel antipsychotic drug, inhibits quinpriole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum

Inoue, A., Miki, S., Seto, M., Kikuchi, T., Morita, S., Ueda, H., Misu, Y., & Nakata, Y. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00920-x · Cited by 103 · see citing works

Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis

Iyo, M., Tadokoro, S., Kanahara, N., Hashimoto, T., Niitsu, T., Watanabe, H., & Hashimoto, K. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31828ea95c · Cited by 98 · see citing works

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia

Suzuki, T., Kanahara, N., Yamanaka, H., Takase, M., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.02.021 · Cited by 81 · see citing works

Effects of stringent criteria on eligibility for clozapine among public mental health clients

Juarez-Reyes, M. G., Shumway, M., Battle, C., Bacchetti, P., Hansen, M. S., & Hargreaves, W. A. (1995) · Psychiatric Services · doi:10.1176/ps.46.8.801 · Cited by 65 · see citing works

Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies

Huang, N. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00093-9 · Cited by 57 · see citing works

A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis

Fallon, P., & Dursun, S. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109359097 · Cited by 56 · see citing works

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sasaki, T., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.022 · Cited by 55 · see citing works

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia

Takase, M., Kanahara, N., Oda, Y., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115570083 · Cited by 54 · see citing works

The Concept of Supersensitivity Psychosis

Kirkpatrick, B. W., Alphs, L. D., & Buchanan, R. W. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199204000-00009 · Cited by 41 · see citing works

Effects of haloperidol on rat behavior and density of dopaminergic D2-like receptors

Vasconcelos, S. M. M., Nascimento, V. S., Nogueira, C. R. A., Vieira, C. M. A. G., Sousa, F. C. F., Fonteles, M. M. D. F., & Viana, G. S. D. B. (2003) · Behavioural Processes · doi:10.1016/s0376-6357(03)00028-7 · Cited by 38 · see citing works

Maintenance Treatment of Severe Tardive Dyskinesia With Clozapine

Louzã, M. R., & Bassitt, D. P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155823.59585.88 · Cited by 37 · see citing works

A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers

Köhler, U., Schröder, H., Augustin, W., & Sabel, B. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90248-8 · Cited by 29 · see citing works

Prospective, Open Study of Long-Acting Injected Risperidone versus Oral Antipsychotics in 88 Chronically Psychotic Patients

Girardi, P., Serafini, G., Pompili, M., Innamorati, M., Tatarelli, R., & Baldessarini, R. J. (2010) · Pharmacopsychiatry · doi:10.1055/s-0029-1239541 · Cited by 15 · see citing works

Potential treatment strategy of risperidone in long-acting injectable form for schizophrenia with dopamine supersensitivity psychosis

Kimura, H., Kanahara, N., Watanabe, H., & Iyo, M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.008 · Cited by 14 · see citing works

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 607 · see citing works

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270 · see citing works

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works

Clozapine discontinuation withdrawal symptoms in schizophrenia

Blackman, G., & Oloyede, E. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211032053 · Cited by 54 · see citing works

Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice

Nakata, Y., Kanahara, N., & Iyo, M. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117728428 · Cited by 53 · see citing works

Current and emerging long-acting antipsychotics for the treatment of schizophrenia

de Filippis, R., Fazio, P. D., Gaetano, R., Steardo, L., Cedro, C., Bruno, A., Zoccali, R., & Muscatello, M. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1910674 · Cited by 43 · see citing works

Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management

Salem, H., Pigott, T. A., Zhang, X. Y., Zeni, C., & Teixeira, A. L. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1361322 · Cited by 31 · see citing works

A critical appraisal of long acting injectable antipsychotics: Translating research to clinics.

Sreeraj, V., Shivakumar, V., Rao, N.-R. P., & Venkatasubramanian, G. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.03.018 · Cited by 20 · see citing works

Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents

Kannarkat, G. T., Caroff, S. N., & Morley, J. F. (2022) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.695 · Cited by 18 · see citing works

Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)

Yang, K.-C., Liao, Y.-T., Yang, Y.-K., Lin, S.-K., Liang, C.-S., & Bai, Y. (2021) · CNS Drugs · doi:10.1007/s40263-021-00838-5 · Cited by 16 · see citing works

Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia

Kanahara, N., Kimura, H., Oda, Y., Ito, F., & Iyo, M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210125152815 · Cited by 14 · see citing works

A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study

Niitsu, T., Hata, T., Nishimoto, M., Hosoda, Y., Kimura, A., Oda, Y., Suzuki, M., Takase, N., Seki, R., Fujita, K., et al. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102369 · Cited by 14 · see citing works

Rationale and neurobiological effects of treatment with antipsychotics in patients with chronic schizophrenia considering dopamine supersensitivity

Kimura, H., Kanahara, N., & Iyo, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113126 · Cited by 14 · see citing works

Continuous versus extended antipsychotic dosing in schizophrenia: Less is more

Servonnet, A., Uchida, H., & Samaha, A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113076 · Cited by 13 · see citing works

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia

Oishi, K., Kanahara, N., Takase, M., Oda, Y., Nakata, Y., Niitsu, T., Ishikawa, M., Sato, Y., & Iyo, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207133 · Cited by 8 · see citing works

Schizophrenia and Related Psychoses

(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg001 · Cited by 8 · see citing works

The phenomenon of therapeutic resistance in the treatment of schizophrenia: the possibilities of modern diagnostics and methods of anti-resistant effects

Stanovaya, V. V., Guseynova, Z. T., Ivanov, M. V., & Bigday, E. V. (2023) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2023-893 · Cited by 6 · see citing works

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients

Suda, A., Hattori, S., Kishida, I., Miyauchi, M., Shiraishi, Y., Fujibayashi, M., Tsujita, N., Ishii, C., Ishii, N., Moritani, T., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s173617 · Cited by 5 · see citing works

Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia

Masumo, Y., Kanahara, N., Kogure, M., Yamasaki, F., Nakata, Y., & Iyo, M. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000442 · Cited by 5 · see citing works

Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice

Yamasaki, F., Kanahara, N., Nakata, Y., Koyoshi, S., Yanagisawa, Y., Saito, T., Oiwa, T., Kogure, M., Sasaki, T. G., Yoshida, T., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231177268 · Cited by 5 · see citing works

Treatment of Clozapine Nonresponders

Grover, S., & Sahoo, S. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-0166-4 · Cited by 4 · see citing works

Long-Term Treatment With Long-Acting Injectable Antipsychotic in Schizophrenia Patients With and Without Dopamine Supersensitivity Psychosis

Kogure, M., Kanahara, N., Kimura, M., Hanaoka, S., Hirano, H., & Iyo, M. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001564 · Cited by 2 · see citing works

Extended (alternate day) antipsychotic dosing and dopamine supersensitivity psychosis: A case report

Kumar, V., & Venkatasubramanian, G. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.009 · Cited by 1 · see citing works

Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases

Kanahara, N., Kimura, H., Kinoshita, T., Iyo, M., & Takekita, Y. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.197 · Cited by 1 · see citing works

Study on multimodal functional magnetic resonance images of schizophrenic patients with initial negative symptom

Huang, R., Li, H. A., Sun, L., Xu, B. J., & Ma, X. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-1849

Breakthrough Psychosis and Long-Acting Injectable Antipsychotics

Joo, E.-J., Lee, K. Y., Jeong, S. H., & Kim, Y. S. (2023) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2023.26.1.1

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sasaki, T., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.022 · Cited by 55 · see citing works

Long-acting injectable risperidone in treatment refractory patients: A 14-week open-label pilot study

Procyshyn, R. M., Barr, A. M., Flynn, S., Schenk, C., Ganesan, S., & Honer, W. G. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.016 · Cited by 7 · see citing works

2742 – A Prospective Comparative Study of Risperidone Long-Acting Injection For Treatment-Resistant Schizophrenia with Dopamine Supersensitivity Psychosis

Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K. T., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sekine, Y., et al. (2013) · European Psychiatry · doi:10.1016/s0924-9338(13)77342-5

A six month randomized controlled trial of long acting injectable risperidone 50 and 100 mg in treatment resistant schizophrenia

Meltzer, H. Y., Lindenmayer, J., Kwentus, J., Share, D. B., Johnson, R., & Jayathilake, K. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.015 · Cited by 38 · see citing works

Aripiprazole Long-acting Injectable Two-injection Start to Manage Supersensitivity Psychosis: A Case Report

Cıvan, H. Y. (2025) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.25.1284 · Cited by 1 · see citing works